The Scientific Advisory Board (SAB) of the Foundation reads as a Who’s Who of CLL research. The SAB ensures that the clinical and scientific aspects of the research are of the highest order of integrity and originality. They provide oversight to ensure the research is conducted with the highest ethical standard. The Scientific Advisory Board oversees the development and implementation of the submission, evaluation, and funding processes for clinical research proposals.
William Plunkett, Ph.D. (chair)
University of Texas MD Anderson Cancer Center
Federico Caligaris-Cappio, M.D.
Instituto Scientifico San Raffaele
Milan, Italy
Daniel Catovsky, M.D., DSc Emeritus Professor
Section of Hemato-Oncology
Institute of Cancer Research, UK
Carlo Croce, M.D.
The Ohio State University Comprehensive Cancer Center
The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Neil Kay, M.D.
Mayo Clinic
Raymond Meyn, Ph.D.
University of Texas MD Anderson Cancer Center
Susan O’Brien, M.D.
University of Texas MD Anderson Cancer Center
Kanti Rai, M.D.
Long Island Jewish Medical Center
Steven Rosen, M.D.
Robert H. Lurie Comprehensive Cancer Center
Northwestern University (Chicago)
William Wierda, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
